REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.
It is not known if REBLOZYL is safe or effective in children under 18 years of age.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Be sure to talk to your healthcare team about what you should write down and track between REBLOZYL injections. This may include:
It’s likely you will have questions about REBLOZYL during your treatment journey. There is a lot of new information to learn and a lot of things to keep track of. It’s important to talk with your healthcare team—they are here to help you along your journey.
Here are a few questions that can start the conversation with your healthcare team:
Be sure to tell your healthcare team how you are feeling while taking REBLOZYL and talk about any changes in dose over time.
Explore more resources for starting and staying with REBLOZYL.